Gülseren Araş

713 total citations
41 papers, 516 citations indexed

About

Gülseren Araş is a scholar working on Surgery, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gülseren Araş has authored 41 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 17 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gülseren Araş's work include Thyroid Cancer Diagnosis and Treatment (15 papers), Medical Imaging and Pathology Studies (7 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Gülseren Araş is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (15 papers), Medical Imaging and Pathology Studies (7 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Gülseren Araş collaborates with scholars based in Türkiye, United States and United Kingdom. Gülseren Araş's co-authors include Ömer Küçük, Mine Araz, Elgin Özkan, Aydan Kansu, Nurten Girgin, Ayhan Gazi Kalaycı, Erkan İbiş, Çiğdem Soydal, Murat Faik Erdoğan and Mahmut Koç and has published in prestigious journals such as PEDIATRICS, European Journal of Endocrinology and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Gülseren Araş

40 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gülseren Araş Türkiye 13 240 206 133 117 108 41 516
Osama Al‐Saif Saudi Arabia 11 118 0.5× 168 0.8× 67 0.5× 146 1.2× 16 0.1× 30 480
Yen‐Kung Chen Taiwan 12 82 0.3× 150 0.7× 182 1.4× 47 0.4× 11 0.1× 34 494
Bedii Kanmaz Türkiye 11 88 0.4× 148 0.7× 147 1.1× 165 1.4× 5 0.0× 28 476
Masaru Tsuchiya Japan 13 55 0.2× 454 2.2× 25 0.2× 167 1.4× 26 0.2× 36 760
J M Miranda Mexico 10 89 0.4× 50 0.2× 38 0.3× 27 0.2× 38 0.4× 10 453
Yu‐Chien Shiau Taiwan 13 21 0.1× 163 0.8× 163 1.2× 59 0.5× 18 0.2× 50 492
J. G. Bova United States 11 22 0.1× 348 1.7× 35 0.3× 58 0.5× 55 0.5× 14 458
G. Kumnig Austria 11 280 1.2× 209 1.0× 308 2.3× 41 0.4× 3 0.0× 17 648
P D Radecki United States 10 110 0.5× 246 1.2× 92 0.7× 27 0.2× 4 0.0× 15 386
Luis Alberto Ramírez Colombia 10 236 1.0× 122 0.6× 64 0.5× 34 0.3× 7 0.1× 20 595

Countries citing papers authored by Gülseren Araş

Since Specialization
Citations

This map shows the geographic impact of Gülseren Araş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gülseren Araş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gülseren Araş more than expected).

Fields of papers citing papers by Gülseren Araş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gülseren Araş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gülseren Araş. The network helps show where Gülseren Araş may publish in the future.

Co-authorship network of co-authors of Gülseren Araş

This figure shows the co-authorship network connecting the top 25 collaborators of Gülseren Araş. A scholar is included among the top collaborators of Gülseren Araş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gülseren Araş. Gülseren Araş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Araz, Mine, Gülseren Araş, & Ömer Küçük. (2015). The role of 18F–NaF PET/CT in metastatic bone disease. Journal of bone oncology. 4(3). 92–97. 55 indexed citations
2.
Soydal, Çiğdem, et al.. (2014). Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment. Nuclear Medicine Communications. 36(2). 109–113. 4 indexed citations
3.
Soydal, Çiğdem, et al.. (2013). Evaluation of the Response to Selective Internal Radiation Therapy in Patients With Hepatocellular Cancer According to Pretreatment 99mTc-MAA Uptake. Clinical Nuclear Medicine. 38(4). 252–255. 5 indexed citations
6.
Özkan, Elgin, Çiğdem Soydal, Mine Araz, Gülseren Araş, & Erkan İbiş. (2012). The Additive Clinical Value of 18F-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels. Clinical Nuclear Medicine. 37(8). 755–758. 31 indexed citations
7.
Küçük, Ömer, et al.. (2009). Evaluation of Extrapulmonary Ga-67 Uptake in Sarcoidosis: A Retrospective Analysis. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(2). 375–380. 1 indexed citations
8.
Araş, Gülseren, et al.. (2009). Intraoperative gamma probe guidance with 99mTc-pertechnetate in the completion thyroidectomy. Annals of Nuclear Medicine. 23(5). 421–426. 4 indexed citations
10.
Küçük, Ömer, et al.. (2007). Treatment for Microcarcinoma of the Thyroid—Clinical Experience. Clinical Nuclear Medicine. 32(4). 279–281. 53 indexed citations
11.
Küçük, Ömer, et al.. (2006). Clinical importance of anti-thyroglobulin auto-antibodies in patients with differentiated thyroid carcinoma: Comparison with 99mTc-MIBI scans. Nuclear Medicine Communications. 27(11). 873–876. 12 indexed citations
12.
Küçük, Ömer, et al.. (2006). Hürthle cell carcinoma: a clinicopathological study of thirteen cases. Nuclear Medicine Communications. 27(4). 377–379. 7 indexed citations
13.
Küçük, Ömer, et al.. (2005). Mediastinal intraoperative radioisotope sentinel lymph node mapping in non-small-cell lung cancer. Nuclear Medicine Communications. 26(8). 717–720. 11 indexed citations
14.
Küçük, Ömer, et al.. (2002). A Hypophyseal Metastasis of Follicular Thyroid Carcinoma. Clinical Nuclear Medicine. 27(4). 309–310. 3 indexed citations
15.
Araş, Gülseren, et al.. (2002). Utility of Tc-99m Human Polyclonal Immunoglobulin G Scintigraphy for Assessing the Efficacy of Yttrium-90 Silicate Therapy in Rheumatoid Knee Synovitis. Clinical Nuclear Medicine. 27(6). 395–400. 5 indexed citations
16.
Küçük, Ömer, et al.. (2002). Evaluation of Persistent Edema with Lymphoscintigraphy After Femoral Artery Injury. Clinical Nuclear Medicine. 27(3). 227–228. 1 indexed citations
17.
Deda, Gülhıs, et al.. (2001). Cerebral blood flow abnormalities in symptomatic West syndrome: A single photon emission computed tomography study. Pediatrics International. 43(1). 66–70. 2 indexed citations
18.
Sarikaya, İsmet, Ahmet Bektaş, Erkan İbiş, et al.. (1999). Tc-99m Dextran and Tc-99m HIG Findings in Patients With Ulcerative Colitis. Clinical Nuclear Medicine. 24(4). 243–247. 10 indexed citations
19.
İbiş, Erkan, et al.. (1995). Extraosseous uptake of 99mTechnetium phosphate in an extremity. Seminars in Nuclear Medicine. 25(4). 352–354. 3 indexed citations
20.
İbiş, Erkan, et al.. (1991). Postoperative goitre recurrence rate in Turkey. European Journal of Endocrinology. 125(1). 33–37. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026